Abstract
The response to the harm caused by risk factors related to atherosclerosis may consist of clinical-signs of cardiac and/or blood vessel ischemic pathology sometimes accompanied by arrhythmias and heart failure-, metabolic- signs of altered oxygen transport and pro-thrombotic changes of coagulation-fibrinolysis cascade-, and sympathetic features due to nerve stimulation, which cause changes in heart rate and blood pressure. Moreover, some special categories like women have the responses, which are influenced by their endocrine constellation. There is a different predisposition towards the markers of atherosclerosis in premenopausal woman, who displays atherogenic effects, and in women after the menopause who respond similarly to that of men. Finally, oxidative stress, which is a strong pro-thrombotic factor, increases the development of an atherosclerotic lesion.
From these data, there is no doubt that a large number of factors, primarily smoking and endothelial dysfunction influence the cardiovascular system causing a major incidence of cardiovascular events. In addition, there would be evidence that some factors related to atherosclerosis should be considered as an etiologic (causal) factor of cardiovascular alterations because they can lead, in the long run, to an irreversible damage to the heart and blood vessels.
Keywords: Smoking, endothelium, atherosclerotic markers.
Current Pharmaceutical Design
Title:Markers of Atherosclerotic Disease: What do they Mean? Current Opinion and Future Trends
Volume: 22 Issue: 1
Author(s): Aurelio Leone
Affiliation:
Keywords: Smoking, endothelium, atherosclerotic markers.
Abstract: The response to the harm caused by risk factors related to atherosclerosis may consist of clinical-signs of cardiac and/or blood vessel ischemic pathology sometimes accompanied by arrhythmias and heart failure-, metabolic- signs of altered oxygen transport and pro-thrombotic changes of coagulation-fibrinolysis cascade-, and sympathetic features due to nerve stimulation, which cause changes in heart rate and blood pressure. Moreover, some special categories like women have the responses, which are influenced by their endocrine constellation. There is a different predisposition towards the markers of atherosclerosis in premenopausal woman, who displays atherogenic effects, and in women after the menopause who respond similarly to that of men. Finally, oxidative stress, which is a strong pro-thrombotic factor, increases the development of an atherosclerotic lesion.
From these data, there is no doubt that a large number of factors, primarily smoking and endothelial dysfunction influence the cardiovascular system causing a major incidence of cardiovascular events. In addition, there would be evidence that some factors related to atherosclerosis should be considered as an etiologic (causal) factor of cardiovascular alterations because they can lead, in the long run, to an irreversible damage to the heart and blood vessels.
Export Options
About this article
Cite this article as:
Leone Aurelio, Markers of Atherosclerotic Disease: What do they Mean? Current Opinion and Future Trends, Current Pharmaceutical Design 2016; 22 (1) . https://dx.doi.org/10.2174/1381612822666151109111311
DOI https://dx.doi.org/10.2174/1381612822666151109111311 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Adipose Tissue: The Link Between Obesity and Cardiovascular Disease
Cardiovascular & Hematological Disorders-Drug Targets Crystallization and Preliminary X-Ray Analysis of the Highly Thermostable Sweet Protein Mabinlin II
Protein & Peptide Letters Inhibitory Role of Resveratrol in the Development of Profibrogenesis and Fibrosis Mechanisms
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Systemic Sclerosis-Related Pulmonary Hypertension: Unique Characteristics and Future Treatment Targets
Current Pharmaceutical Design Non-Steroidal Anti-Inflammatory Drugs used as a Treatment Modality in Subarachnoid Hemorrhage
Current Drug Safety In Vitro CYP2D Inhibitory Effect and Influence on Pharmacokinetics and Pharmacodynamic Parameters of Metoprolol Succinate by Terminalia arjuna in Rats
Drug Metabolism Letters Subclinical Hypothyroidism and Cognitive Dysfunction in the Elderly
Endocrine, Metabolic & Immune Disorders - Drug Targets The Use of Bifunctional NOP/Mu and NOP Receptor Selective Compounds for the Treatment of Pain, Drug Abuse, and Psychiatric Disorders
Current Pharmaceutical Design Treatment of Hypertensive Left Ventricular Hypertrophy
Current Pharmaceutical Design Thrombin Inhibitors and Anti-Factor Xa Agents in the Treatment of Arterial Occlusion
Current Drug Targets Recent Progress in the Therapeutic Role of Serelaxin in Vascular Dysfunction
Current Protein & Peptide Science The Concept of Titration can be Transposed to Fluid Management. But does is Change the Volumes? Randomised Trial on Pleth Variability Index During Fast-Track Colonic Surgery
Current Clinical Pharmacology Salvaging the Ischemic Heart: Gi-Coupled Receptors in Mast Cells Activate a PKCε/ALDH2 Pathway Providing Anti-RAS Cardioprotection
Current Medicinal Chemistry Artificial Intelligence as a Business Partner in Cardiovascular Precision Medicine: An Emerging Approach for Disease Detection and Treatment Optimization
Current Medicinal Chemistry Advanced Cardiac Imaging of Radiation-induced Injury - a Review
Current Medical Imaging Clinical Applications of Cardiovascular Magnetic Resonance
Current Pharmaceutical Design The Ubiquitin-Proteasome System and Proteasome Inhibitors in Central Nervous System Diseases
Cardiovascular & Hematological Disorders-Drug Targets SIRT1 Promotes Neuronal Fortification in Neurodegenerative Diseases through Attenuation of Pathological Hallmarks and Enhancement of Cellular Lifespan
Current Neuropharmacology Autoimmunity and Apoptosis - Therapeutic Implications
Current Medicinal Chemistry Editorial (Thematic Issue: Novel Therapeutic Strategies for Cardiovascular Disease Treatment: From Molecular Level to Nanotechnology)
Current Pharmaceutical Design